Cargando…
Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups
To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231688/ https://www.ncbi.nlm.nih.gov/pubmed/30419067 http://dx.doi.org/10.1371/journal.pone.0207492 |
_version_ | 1783370279776419840 |
---|---|
author | Ingelbeen, Brecht Bruyand, Mathias Mariani-Kurkjian, Patricia Le Hello, Simon Danis, Kostas Sommen, Cécile Bonacorsi, Stéphane de Valk, Henriette |
author_facet | Ingelbeen, Brecht Bruyand, Mathias Mariani-Kurkjian, Patricia Le Hello, Simon Danis, Kostas Sommen, Cécile Bonacorsi, Stéphane de Valk, Henriette |
author_sort | Ingelbeen, Brecht |
collection | PubMed |
description | To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013–16. STEC was isolated from 153/521 (30%) reported HUS cases: 45 serogroup O80, 46 O157 and 62 other serogroups. Median ages were 1.1 years, 4.0 years and 1.8 years, respectively. O80 infected patients were less likely to report ground beef consumption (aOR [adjusted Odds Ratio] 0.14 95% CI [Confidence Interval] 0.02–0.80) or previous contact with a person with diarrhea or HUS (aOR 0.13 95%CI 0.02–0.78) than patients infected with STEC O157. They were also less likely to report previous contact with a person presenting with diarrhea/HUS than patients infected with other serogroups (aOR 0.13 95%CI 0.02–0.78). STEC O80 spread all over France among young children less exposed to known risk factors of O157 or other STEC infections, suggesting the existence of different reservoirs and transmission patterns. |
format | Online Article Text |
id | pubmed-6231688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-62316882018-11-19 Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups Ingelbeen, Brecht Bruyand, Mathias Mariani-Kurkjian, Patricia Le Hello, Simon Danis, Kostas Sommen, Cécile Bonacorsi, Stéphane de Valk, Henriette PLoS One Research Article To generate hypotheses on possible sources of Shiga toxin-producing Escherichia coli (STEC) serogroup O80 associated hemolytic-uremic syndrome (HUS), we explored differences in factors associated with STEC O80 associated HUS, compared with STEC O157 or STEC of other serogroups, in France during 2013–16. STEC was isolated from 153/521 (30%) reported HUS cases: 45 serogroup O80, 46 O157 and 62 other serogroups. Median ages were 1.1 years, 4.0 years and 1.8 years, respectively. O80 infected patients were less likely to report ground beef consumption (aOR [adjusted Odds Ratio] 0.14 95% CI [Confidence Interval] 0.02–0.80) or previous contact with a person with diarrhea or HUS (aOR 0.13 95%CI 0.02–0.78) than patients infected with STEC O157. They were also less likely to report previous contact with a person presenting with diarrhea/HUS than patients infected with other serogroups (aOR 0.13 95%CI 0.02–0.78). STEC O80 spread all over France among young children less exposed to known risk factors of O157 or other STEC infections, suggesting the existence of different reservoirs and transmission patterns. Public Library of Science 2018-11-12 /pmc/articles/PMC6231688/ /pubmed/30419067 http://dx.doi.org/10.1371/journal.pone.0207492 Text en © 2018 Ingelbeen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ingelbeen, Brecht Bruyand, Mathias Mariani-Kurkjian, Patricia Le Hello, Simon Danis, Kostas Sommen, Cécile Bonacorsi, Stéphane de Valk, Henriette Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title | Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title_full | Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title_fullStr | Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title_full_unstemmed | Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title_short | Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups |
title_sort | emerging shiga-toxin-producing escherichia coli serogroup o80 associated hemolytic and uremic syndrome in france, 2013-2016: differences with other serogroups |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231688/ https://www.ncbi.nlm.nih.gov/pubmed/30419067 http://dx.doi.org/10.1371/journal.pone.0207492 |
work_keys_str_mv | AT ingelbeenbrecht emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT bruyandmathias emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT marianikurkjianpatricia emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT lehellosimon emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT daniskostas emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT sommencecile emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT bonacorsistephane emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups AT devalkhenriette emergingshigatoxinproducingescherichiacoliserogroupo80associatedhemolyticanduremicsyndromeinfrance20132016differenceswithotherserogroups |